KMPR 10-Q Quarterly Report March 31, 2024

KEMPER CORP

10-Ks and 10-Qs

10-Q	Quarter ended March 31, 2024
10-K	Fiscal year ended Dec. 31, 2023
10-Q	Quarter ended Sept. 30, 2023
10-Q	Quarter ended June 30, 2023
10-Q	Quarter ended March 31, 2023
10-K	Fiscal year ended Dec. 31, 2022
10-Q	Quarter ended Sept. 30, 2022
10-Q	Quarter ended June 30, 2022
10-Q	Quarter ended March 31, 2022
10-K	Fiscal year ended Dec. 31, 2021
10-Q	Quarter ended Sept. 30, 2021
10-Q	Quarter ended June 30, 2021
10-Q	Quarter ended March 31, 2021
10-K	Fiscal year ended Dec. 31, 2020
10-Q	Quarter ended Sept. 30, 2020
10-Q	Quarter ended June 30, 2020
10-Q	Quarter ended March 31, 2020
10-K	Fiscal year ended Dec. 31, 2019
10-Q	Quarter ended Sept. 30, 2019
10-Q	Quarter ended June 30, 2019
10-Q	Quarter ended March 31, 2019
10-K	Fiscal year ended Dec. 31, 2018
10-Q	Quarter ended Sept. 30, 2018
10-Q	Quarter ended June 30, 2018
10-Q	Quarter ended March 31, 2018
10-K	Fiscal year ended Dec. 31, 2017
10-Q	Quarter ended Sept. 30, 2017
10-Q	Quarter ended June 30, 2017
10-Q	Quarter ended March 31, 2017
10-K	Fiscal year ended Dec. 31, 2016
10-Q	Quarter ended Sept. 30, 2016
10-Q	Quarter ended June 30, 2016
10-Q	Quarter ended March 31, 2016
10-K	Fiscal year ended Dec. 31, 2015
10-Q	Quarter ended Sept. 30, 2015
10-Q	Quarter ended June 30, 2015
10-Q	Quarter ended March 31, 2015
10-K	Fiscal year ended Dec. 31, 2014
10-Q	Quarter ended Sept. 30, 2014
10-Q	Quarter ended June 30, 2014
10-Q	Quarter ended March 31, 2014
10-K	Fiscal year ended Dec. 31, 2013
10-Q	Quarter ended Sept. 30, 2013
10-Q	Quarter ended June 30, 2013
10-Q	Quarter ended March 31, 2013
10-K	Fiscal year ended Dec. 31, 2012
10-Q	Quarter ended Sept. 30, 2012
10-Q	Quarter ended June 30, 2012
10-Q	Quarter ended March 31, 2012
10-K	Fiscal year ended Dec. 31, 2011
10-Q	Quarter ended Sept. 30, 2011
10-Q	Quarter ended June 30, 2011
10-Q	Quarter ended March 31, 2011
10-K	Fiscal year ended Dec. 31, 2010
10-Q	Quarter ended Sept. 30, 2010
10-Q	Quarter ended June 30, 2010
10-Q	Quarter ended March 31, 2010
10-K	Fiscal year ended Dec. 31, 2009

PROXIES

DEF 14A	Filed on March 20, 2024
DEF 14A	Filed on March 22, 2023
DEF 14A	Filed on March 23, 2022
DEF 14A	Filed on March 24, 2021
DEF 14A	Filed on March 25, 2020
DEF 14A	Filed on March 20, 2019
DEF 14A	Filed on March 24, 2017
DEF 14A	Filed on March 24, 2016
DEF 14A	Filed on March 27, 2015
DEF 14A	Filed on March 28, 2014
DEF 14A	Filed on March 22, 2013
DEF 14A	Filed on March 23, 2012
DEF 14A	Filed on March 28, 2011
DEF 14A	Filed on March 29, 2010

TABLE OF CONTENTS

Part I. Financial Information Item 1. Financial Statements Note 1 - Basis Of Presentation and Accounting Policies Note 1 - Basis Of Presentation and Accounting Policies (continued)Note 2 - Net Income (loss) Per Unrestricted Share Note 3 - Business Segments Note 3 - Business Segments (continued)Note 4 - Property and Casualty Insurance Reserves Note 4 - Property and Casualty Insurance Reserves (continued)Note 5 - Liability For Future Policyholder Benefits Note 5 - Liability For Future Policyholder Benefits (continued)Note 6 - Investments Note 6 - Investments (continued)Note 7 - Derivatives Note 7 - Derivatives (continued)Note 8 - Fair Value Measurements Note 8 - Fair Value Measurements (continued)Note 9 - Variable Interest Entities Note 9 - Variable Interest Entities (continued)Note 10 - Deferred Policy Acquisition Costs Note 11 - Receivables From Policyholders - Allowance For Expected Credit Losses Note 12 - Other Comprehensive Income and Accumulated Other Comprehensive Loss Note 13 - Shareholders Equity Note 13 - Shareholders Equity (continued)Note 14 - Policyholder Obligations Note 15 - Debt Note 15 - Debt (continued)Note 16 - Leases Note 16 - Leases (continued)Note 17 - Income Taxes Note 17 - Income Taxes (continued)Note 18 - Commitments and Contingencies Item 2. Management S Discussion and Analysis Of Financial Condition and Results Of Operations Note 15, Debt, To The Condensed Consolidated Financial Statements For More Information Regarding The Company S Long-term Debt Item 3. Quantitative and Qualitative Disclosures About Market Risk Item 4. Controls and Procedures Part II - Other Information Item 1. Legal Proceedings Item 1A. Risk Factors Item 2. Unregistered Sales Of Equity Securities and Use Of Proceeds Item 5. Market For Registrant S Common Equity, Related Stockholder Matters and Issuer Purchases Of Equity Securities Item 6. Exhibits

Exhibits

10.1 Separation and Release Agreement 8-K 001-18298 10.1 January 25, 2024 10.2 Form of Restricted Stock Unit Award Agreement (ELT Retention) as of February 6, 2024 under the 2023 Omnibus Plan 31.1 Certification of Chief Executive Officer Pursuant to SEC Rule 13a-14(a) 31.2 Certification of Chief Financial Officer Pursuant to SEC Rule 13a-14(a) 32.1 Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 32.2 Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Supplier name	Ticker
Aon Plc	AON
The Hartford Financial Services Group, Inc.	HIG
Amgen Inc.	AMGN
Bristol-Myers Squibb Company	BMY
Fidelity National Information Services, Inc.	FIS
AbbVie Inc.	ABBV

KMPR 10-Q Quarter ended March 31, 2024

Exhibits